Skip to content
Most popular
Read moreMDFA showcases groundbreaking research projects in new impact report
Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.
Read moreCould a new supplement help slow AMD?
A/Prof Gerald Liew’s second MDFA Research Grant is allowing him to investigate a potential sight-saving supplement to improve dysfunctional mitochondria and prevent age-related macular degeneration (AMD).
Read moreResearch study measuring the impact of AMD on quality of life
If you have AMD, you could help this MDFA-funded study.
Read morePotential treatment for atrophic AMD on the horizon
Results have now been presented at medical conferences in the USA.
Read morePotential new treatment for dry AMD
Apellis announces initial results from two phase III studies in geographic atrophy.
Read moreWellbeing and AMD
MDFA funded researcher Ms Diana Tang is rolling out the Movement, Interaction and Nutrition for Greater Lifestyles in the Elderly – or MINGLE – program.
Read moreCreating the perfect laboratory macula model
MDFA funded researcher, Dr Anai Gonzalez Cordero is creating an organoid – essentially a mini organ in a dish – with a macular structure.
Read moreMDFA awards $1 million to eight exciting research projects
MDFA has awarded more than $1 million in research funding to eight promising projects, in the search for a cure for macular diseases.
Read more10 years of MDFA Research Grants
Celebrating the 10th anniversary of MDFA’s Research Grants Program, this free publication introduces you to the talented researchers your donations have funded since 2011.
Read moreGrant Family Fund bequest: Lasting legacy to ‘best mates’
Faye Grant included MDFA in her Will. Her bequest is now funding vital, innovative research into macular disease through the Grant Family Fund.
Read moreScientists test potential drug developed in Australia
A new chemical compound could become a future tool against retinal vascular disease. The finding is the result of a pre-clinical study, led by UNSW researchers.
Most recent
2025 Research Grant Recipient
Driving into the future: strategies to enhance independence for drivers with macular degeneration, including licensing options and the role of modern vehicle technology
2025 Grant Family Fund Award Recipient
Exploring exosomal therapeutics delivery strategies for macular disease
2025 Research Grant Recipient
Reducing the risk of end-stage complications of neovascular age-related macular degeneration (AMD): macular atrophy and subretinal fibrosis
2025 Research Grant Recipient
Towards a personalised approach to predicting and preventing progression of age-related macular degeneration
2025 Research Grant Recipient
Genotype-phenotype correlations in PRPH2-associated retinal dystrophy
2025 Research Grant Recipient
Nocturnal hypoxia: An unrecognised risk factor for neovascular age-related macular degeneration
2025 Grant Family Fund Award Recipient
Macular vascular disease: software standardisation and data harmonisation to accelerate the development of new imaging biomarkers and therapies
2025 Grant Family Fund Award Recipient
Next-generation gene therapy for Stargardt Disease: Enhanced AAV-mediated ABCA4 delivery to restore vision
$1 million investment in new macular disease research
MDFA is Australia’s largest source of research funding in the field of macular disease outside of government.